CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 70 enrolled
Drug / intervention
Norco +1 moredrug
Likely dose
Norco 5mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03457116
NCT03457116Phase 4Completed
CompareCT.gov

Narcotics vs Non-steroidal Ant Inflammatory Drugs Post-operative Analgesia in Outpatient Rhinoplasty

NYU Langone Health·interventional·Posted Mar 7, 2018·Updated Nov 23, 2021

In Brief

A Phase 4 clinical trial evaluating Norco and NSAID for Rhinoplasty and 2 related conditions. Completed, enrolled 70 participants across 1 site.

Detailed Summary

The purpose of this study is to compare the efficacy and safety of oral opiate pain medication vs non-steroidal ant inflammatory drugs (NSAIDs) in the treatment of postoperative rhinoplasty pain. This study will also evaluate potential contributing factors affecting the efficacy of these pain control methods. Patients will be randomized to receive either NSAIDs in the form of 400mg of Ibuprofen or Norco (hydrocodone 5mg- acetaminophen 325mg) to be used for post-operative pain. The study will then compare which is more effective in controlling post operative pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRhinoplasty, Non-steroidal Ant Inflammatory Drugs, Opioid Use
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedMar 7, 2018
Enrollment StartJan 30, 2018
Primary CompletionNov 2, 2020
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 8.3 years ago

Interventions

Norcodrug

20 tablets of Hydrocodone 5mg-Acetaminophen 325mg (Norco)

NSAIDdrug

Ibuprofen 400mg for post-operative pain